The Canines-N-Kids Medical & Scientific Advisory Group (MSAG) is comprised of leaders and experts in pediatric and veterinary oncology, translational research, comparative oncology, genomics and specialty clinical practice. The MSAG shapes the Canines-N-Kids Foundation's funding priorities, and makes funding recommendations consistent with these priorities. We are honored to have serving in this important capacity:
Pediatrics, Hematology-Oncology, Greehey Children’s Cancer Research Institute, University of Texas, San Antonio
Head of Emerging Technologies, CM,SO, Novartis Institutes for BioMedical Research (NIBR), Inc.
Orthopaedic Oncologist, Duke University Cancer Institute and North Carolina State College of Veterinary Medicine.
Professor, Radiation Oncologist and Researcher, UC Davis School of Veterinary Medicine; Director, Center for Companion Animal Health, University of California
California Institute for Biomedical Research
Corinne Mary Linardic, PhD, MD
Associate Professor of Pediatrics, Duke University Cancer Institute
Member, St. Jude Faculty; Chair, Department of Bone Marrow Transplantation & Cellular Therapy; Endowed Chair in Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital
Director, Greehey Children's Cancer Research Institute; Professor, Molecular Medicine, University of Texas, San Antonio
Katherine A. Janeway, MD, MMSc
Assistant Professor of Pediatrics, Harvard Medical School
Senior Physician and Director Solid Tumor Service, Pediatric Oncology, Dana-Farber / Boston Children's Cancer and Blood Disorders Center
Vice Chair of the Bone Tumor Committee of the Children’s Oncology Group (COG)
Director, Comparative Oncology Program; National Cancer Institute
Abramson Cancer Center, University of Pennsylvania
Cornell University School of Veterinary Medicine
Professor, Department of Pediatrics and an Adjunct Professor in the Department of Oncological Sciences, School of Medicine at the University of Utah; Investigator, Huntsman Cancer Institute; member of the Nuclear Control of Cell Growth and Differentiation program and Medical Director of the High Risk Pediatric Cancer Clinic,
Lindsay Thalheim, VMD, DACVIM (Oncology)
Staff Oncologist, Cornell University Veterinary Specialists; Adjunct Assistant Clinical Professor of Oncology, Cornell University College of Veterinary Medicine
Associate Professor, Sarcoma Surgical Oncology |Genomic Medicine, UT MD Anderson Cancer Center
Member of the Faculty of Pediatrics, Harvard Medical School
Pediatric Neuro-Oncology, Brain Tumor Center, Dana Farber Cancer Institute & Boston Childrens Hospital